
News
Antibody Drug Conjugates Contract Manufacturing Market to Reach US$20.99 Bn by 2032
The global antibody drug conjugates (ADCs) contract manufacturing market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt targeted cancer therapies. ADCs are